LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD 1.310
-0.085 (-6.09%)
Oct 2, 2026, 4:08 PM HKT
LifeTech Scientific Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,294 | 1,370 | 1,304 | 1,267 | 1,097 | 925.33 |
Revenue Growth | -5.54% | 5.07% | 2.88% | 15.48% | 18.58% | 44.07% |
Gross Profit Gross Profit Growth | 987.25 | 1,019 | 981.44 | 995.64 | 873.93 | 747.53 |
Operating Income Operating Income Growth | 187.04 | 195.41 | 209.71 | 328.5 | 369.07 | 365.77 |
Net Income Net Income Growth | 58.41 | 147.83 | 222.39 | 263.24 | 325.34 | 292.47 |
Earnings Per Share EPS Growth | 0.01 | 0.03 | 0.05 | 0.06 | 0.07 | 0.06 |
EPS Growth | -63.18% | -35.02% | -13.93% | -20.27% | 15.63% | 30.61% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Structural Heart Diseases Business Structural Heart Diseases Business Growth | 440.22 | 511.68 | 527.58 | 495.67 | 394.57 | 331.06 |
Peripheral Vascular Diseases Business Peripheral Vascular Diseases Business Growth | 853.68 | 844.63 | 751.11 | 707.11 | 644.34 | 548.53 |
Cardiac Pacing and Electrophysiology Business Cardiac Pacing and Electrophysiology Business Growth | - | 13.48 | 25.01 | 64.4 | 58.39 | 45.74 |
Total Total Growth | 1,294 | 1,370 | 1,304 | 1,267 | 1,097 | 925.33 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,236 | 1,150 | 1,182 | 1,179 | 833.79 | 1,476 |
Total Debt Total Debt Growth | 14.1 | 8.04 | 4.98 | 9.3 | 9.67 | 15.67 |
Net Cash (Debt) Net Cash Growth | 1,222 | 1,142 | 1,177 | 1,170 | 824.12 | 1,461 |
Net Cash Growth | 7.00% | -2.96% | 0.59% | 41.97% | -43.58% | 52.68% |
Net Cash Per Share Net Cash Per Share Growth | 0.27 | 0.26 | 0.27 | 0.26 | 0.19 | 0.32 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 513.38 | 549.28 | 321.46 | 418.05 | 388.32 | 441.09 |
Capital Expenditures CapEx Growth | -64.63 | -68.47 | -196.64 | -200.83 | -226.37 | -275.82 |
Free Cash Flow Free Cash Flow Growth | 448.75 | 480.81 | 124.83 | 217.22 | 161.95 | 165.27 |
Free Cash Flow Growth | -6.67% | 285.19% | -42.54% | 34.13% | -2.01% | -29.21% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 76.30% | 74.40% | 75.28% | 78.57% | 79.64% | 80.78% |
Operating Margin | 14.46% | 14.27% | 16.09% | 25.92% | 33.63% | 39.53% |
Pretax Margin | 7.72% | 13.98% | 15.26% | 13.86% | 34.45% | 35.98% |
Profit Margin | 4.51% | 10.79% | 17.06% | 20.77% | 29.65% | 31.61% |
FCF Margin | 34.68% | 35.10% | 9.57% | 17.14% | 14.76% | 17.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 93.38 | 43.92 | 27.20 | 37.52 | 32.48 | 47.20 |
Forward PE | - | 14.38 | 15.37 | 22.45 | 20.85 | 31.39 |
P/FCF Ratio | 11.71 | 13.50 | 48.46 | 45.47 | 65.25 | 83.53 |
PS Ratio | 4.06 | 4.74 | 4.64 | 7.79 | 9.63 | 14.92 |